<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cheng X</submitter><funding>National key inspection specialty construction projects</funding><funding>National Key Research and Development Program of China</funding><pagination>323-332</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10920550</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(1)</volume><pubmed_abstract>Strain C1 was successfully isolated from an immunosuppressed patient with persistent bacteremia, who had not previously been exposed to glycopeptide antibiotics. This strain was found to be a heterogeneous vancomycin intermediate-resistant Staphylococcus aureus (hVISA). It is noteworthy that, following a brief period of vancomycin treatment, strains C6, C8, and C9, which were obtained from blood and other body parts, exhibited a significant reduction in heterogeneity as determined by population analysis profile-area under the curve (PAP-AUC) detection. Genotyping analysis revealed that these bacterial strains belonged to the same SCCmecIVa-ST59-t437-agrI genotype and shared the same virulome and resistome. In this study, a comparative genomics analysis was conducted between strain C1 and strain N315 to identify potential hVISA-associated mutations. Ultimately, a total of 205 mutation sites in 19 candidate genes, likely associated with the hVISA phenotype, were identified.</pubmed_abstract><journal>Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]</journal><pubmed_title>Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate-resistant Staphylococcus aureus strain from an immunocompromised patient.</pubmed_title><pmcid>PMC10920550</pmcid><funding_grant_id>2021YFC2301004</funding_grant_id><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Ma J</pubmed_authors><pubmed_authors>Sun W</pubmed_authors><pubmed_authors>Su J</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate-resistant Staphylococcus aureus strain from an immunocompromised patient.</name><description>Strain C1 was successfully isolated from an immunosuppressed patient with persistent bacteremia, who had not previously been exposed to glycopeptide antibiotics. This strain was found to be a heterogeneous vancomycin intermediate-resistant Staphylococcus aureus (hVISA). It is noteworthy that, following a brief period of vancomycin treatment, strains C6, C8, and C9, which were obtained from blood and other body parts, exhibited a significant reduction in heterogeneity as determined by population analysis profile-area under the curve (PAP-AUC) detection. Genotyping analysis revealed that these bacterial strains belonged to the same SCCmecIVa-ST59-t437-agrI genotype and shared the same virulome and resistome. In this study, a comparative genomics analysis was conducted between strain C1 and strain N315 to identify potential hVISA-associated mutations. Ultimately, a total of 205 mutation sites in 19 candidate genes, likely associated with the hVISA phenotype, were identified.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-04-08T18:42:58.317Z</modification><creation>2025-04-04T01:24:29.499Z</creation></dates><accession>S-EPMC10920550</accession><cross_references><pubmed>38057692</pubmed><doi>10.1007/s42770-023-01192-y</doi></cross_references></HashMap>